
“Higher levels of global investment in to the life science and CRO sectors has proven beneficial for the global immunochemicals market. In addition, larger research initiatives towards improving food yield, and nutrition, as well as drug development through genetic engineering is also propelling demand for immunochemicals,” says a Fact.MR analyst